Stingy Investor The Rothery Report
Free Stingy News
Main Rothery Report News Articles Stocks DRPs Brokers Links Free Newsletters
Rothery Report: Login Learn More Performance Sample Subscribe Contact Us
 
MoneySaver Articles
 5 Stingy Stocks for 2008
 5 Graham Stocks for 2008
 Is your index too active?
 Graham's Simple Way
 Canadian Graham Stocks
 5 Stingy Stocks for 2007
 8 Graham Stocks for 2007
 Top SPPs
 The Simple Way
 A hole in your IPO?
 Monkey Business
 8 Stingy Stocks for 2006
 Graham Stock Gainers
 Blue-Chip Blues
 Are Dividends Safe?
 SPPs for 2005
 Graham's Simplest Way
 Selling Graham Stocks
 RRSP Money Market Funds
 Stingy Stocks for 2005
 High Performance Graham
 Intelligent Indexing
 Unbundling Canadian ETFs
 A history of yield
 A Dynamic Duo
 Canadian Graham Stock
 Dividends at Risk
 Thrifty Value Stocks
 Stocks in Short Supply
 The New Dividend
 Hunting Goodwill
 SPPs for 2003
 RRSP: don't panic
 Desirable Dividends
 Stingy Selections 2003
 10 Graham Picks
 Growth Eh?
 Timing Disaster
 Dangerous Diversification
 The Coffee Can Portfolio
 Down with the dogs
 Stingy Selections
 Frugal Funds
 Graham Revisited
 Just Spend It
 Ticker Temptation
 Stock Mortality
 Focus on Fees
 SPPs for the Long Term
 Seeking Solid Stocks
 Relative Strength
 The VR Approach
 The Irrational Investor
 Value Investing
 Eye on PI

MoneySense Articles
 Small stocks, big profits
 Cdn Top 200 2008
 US Top 500 2008
 Value that sizzles
 So simple it works
 Income 100
 No assembly required
 Investing by the book
 Cdn Top 200 2007
 US Top 500 2007
 Invest like the masters
 A simple way to get rich
 Top Trusts 2006
 Stocks for cannibals
 Car bites dogs
 Cdn Top 200 2006
 US Top 1000 2006
 So easy, so profitable
 Top Trusts 2005
 Dogs of the Dow
 Top 200 2005
 Money for nothing
 Yield of dreams
 Return of the master

Norm Speaks










Blue-Chip Blues

I like to look through lists of beaten down stocks for good bargains. Naturally, I don’t expect to find a good value every time but there are often a few candidates that make the search worthwhile. During a recent search I was pleasantly surprised to spot several gleaming brand names languishing unloved in the bargain bin.

This time I started looking for U.S. stocks trading within 20% of their five-year lows. As you might imagine this initial list was quite long. To pare down the list I also demanded that bargain stocks earn at least a dime per share (both overall and from continuing operations). Why a dime per share? I wanted to avoid firms that, via a little accounting hockus pockus, magically managed to earn a few cents per share.

I screened for profitable stocks trading near their five-year lows on September 8 and compiled an impressive list of stocks.

The behemoth at the top of the list is Wal-Mart (WMT, $45.86) which coincidentally makes its profits by setting up innumerable bargain bins for its customers. Due to Wal-Mart’s stupendous size it seems unlikely to be able to continue to grow quickly. However, Wal-Mart’s stock is trading at a 33.5% discount to its five-year high and it has a price-to-earnings ratio of 18.1, which is only a slight premium to the market. Add in Wal-Mart’s modest debt levels and this is one quality stock that seems to have been unfairly discounted.

Next up is the battered and bruised Fannie Mae (FNM, $48.50) which has fallen 45.8% below its five-year high as it struggles with accounting restatements. In addition, investors have become worried that a real-estate collapse would damage Fannie’s mortgage business. Add in a portfolio stuffed with complex derivatives and it takes nerves of steel to hold this one. On the upside, if the company avoids further trouble then its low-low price-to-earnings ratio of 6.3 will be reward enough.

Third on the list is mighty Coca-Cola (KO, $44,28), a long-time Warren Buffett favourite. Unfortunately for Warren the soft-drink giant’s stock has declined 33.8% from its five-year high but Warren’s loss might be our gain. Although Coke has been a frighteningly expensive stock for many years, its current price-to-earnings ratio of 22.0 makes it a relative bargain – at least compared to its own recent history. Investors will also appreciate drinking in Coke’s 2.5% dividend yield, enjoy a decent expected growth rate of 8.1%, and feel fortified by its stable of brand-name sodas.

The fourth stock on my list has unfortunately attracted a swarm of hungry class-action lawyers and its shares trade 68.1% below its five-year high. I’m not talking about big tobacco but drug giant Merck & Co. (MRK, $29.19). The company ran into trouble after it was discovered that Vioxx, its blockbuster arthritis drug, had the nasty habit of increasing the risk of heart attacks and strokes in some patients. While estimated litigation-related costs appear to be gigantic, it hasn’t stopped David Dreman, a noted value investor, from buying Merck shares by the bushel full. He should enjoy Merck’s 5.2% dividend yield while waiting for better times.

The New York Times (NYT, $32.92) is the last big stock on my list. The Time’s stock has fallen 37.9% from its five-year highs amid fears that internet competition will overwhelm it. While many are calling for the demise of the newspaper business, I tend to disagree. After all, newspapers have survived the introduction of other new technologies (such as radio and TV) and their businesses have remained robust. Furthermore, The Times pays a nice dividend yield of 2.0% and trades at a below-market price-to-earnings ratio of 14.5. For new-era investors, it is instructive to compare the Time’s price-to-sales ratio of 1.4 with Google’s (GOOG, $295.39) price-to-sales ratio of 18.4. In this case, I rather suspect that the tried and true will turn out to be a better investment than the hip and new.

Just remember, if you’re looking to nibble at these down-and-out blue-chip stocks then dig deeper to be sure that they are good for your portfolio. Personally, I’ll keep this list close at hand just in case we see a little panicked selling in the fall.

Date: Oct 2005

 

About Legal Contact Us
Disclaimers: Consult with a qualified investment advisor before trading. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. If you need personalized financial advice then please consider our private client services. The information on this site is in no way guaranteed for completeness, accuracy or in any other way.

A Dan Hallett and Associates Inc. publication. Norm Rothery, Ph.D., CFA, is the Chief Investment Strategist at Dan Hallett and Associates Inc. (DH&A) and the founder of StingyInvestor.com. DH&A is registered as Investment Counsel in the province of Ontario. Norm, DH&A, or related-parties may have an interest in the securities mentioned. More...